Evaluating the impact of the HIV pandemic on measles control and elimination

Bulletin of the World Health Organization

Volumn 83, Issue 5, 2005, Pages 329-337

  Helfand, Rita F ^a   Moss, William J ^b   Harpaz, Rafael ^c   Scott, Susana ^d   Cutts, Felicity ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Africa South of the Sahara; Antigen antibody reactions; Child; HIV infections complications; Measles vaccine; Measles immunology epidemiology; Models Statistical

Indexed keywords

MEASLES VACCINE;

HUMAN IMMUNODEFICIENCY VIRUS; MEASLES;

AFRICA; CHILDHOOD MORTALITY; COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; PARAMETER; PREVALENCE; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANTIGEN-ANTIBODY REACTIONS; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MEASLES; MEASLES VACCINE; PREVALENCE;

AFRICA; EASTERN HEMISPHERE; SUB-SAHARAN AFRICA; WORLD;

MEASLES VIRUS;

EID: 18944395544     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Progress in reducing global measles deaths: 1999-2002. Weekly Epidemiological Record 2004;39:20-1.
2. World Health Organization. Mortality reduction and regional elimination: strategic plan 2001-2005. Global measles. Geneva: WHO; 2001. WHO document WHO/V&B/01.15.
3. Nokes DJ, Williams JR, Butler AR. Towards eradication of measles virus: global progress and strategy evaluation. Veterinary Microbiology 1995;44:333-50.
4. Nokes DJ, Swinton J. Vaccination in pulses: a strategy for global eradication of measles and polio? Trends in Microbiology 1997;5:14-9.
5. Fine PE. Herd immunity, history, theory, practice. Epidemiologic Reviews 1993;15:265-302.
6. Advances in global measles control and elimination: summary of the 1997 international meeting. MMWR Recommendations and Reports 1998;47 RR-11:1-23.
7. Moss WJ, Cutts F, Griffin DE. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clinical Infectious Diseases 1999;29:106-12.
8. Progress in reducing global measles deaths. Weekly Epidemiological Record 2003;21:184-7.
9. Global situation of the HIV/AIDS pandemic, end 2003. Weekly Epidemiological Record 2003;49:417-24.
10. UNAIDS. AIDS epidemic update: December 2003. Available from: http://www.unaids.org/Unaids/EN/Resources/Publications/ Corporate+publications/ AIDS+epidemic+update+-+December+2003.asp
11. Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002;359:1564-8.
12. World Health Organization. Southern Africa Integrated Disease Surveillance Network feedback bulletin: December 2000. Harare: WHO Zimbabwe Office: 2000 (also available from: http://www.afro.who.int/ids/bulletins/ southern/dec2000.pdf).
13. World Health Organization. Southern Africa Integrated Disease Surveillance Network feedback bulletin: January 2002. Harare: WHO Zimbabwe Office; 2002 (also available from: http://www.afro.who.int/ids/bulletins/ southern/ jan2002.pdf).
14. World Health Organization. Southern Africa Integrated Disease Surveillance Network feedback bulletin: January 2003. Harare: WHO Zimbabwe Office; 2003 (also available from: http://www.afro.who.int/csr/ids/bulletins/ southern/jan2003.pdf).
15. Halsey N. The optimal age for administering measles vaccine in developing countries. In: Halsey N, de Quadros CA, editors. Recent advances in immunization: a bibliographic review. Washington, DC: Pan American Health Organization; 1983. pp. 4-17.
16. Global situation of the HIV/AIDS pandemic, end 2001. Part 1. Weekly Epidemiological Report 2001;49:381-6.
17. UNAIDS. Report on the Global HIV/AIDS Epidemic: June 2000. Geneva: UNAIDS; 2000 (UNAIDS/00.13E).
18. UNAIDS, World Health Organization. Global HIV/AIDS and STD surveillance: epidemiologic fact sheets by country. Geneva: UNAIDS; 2002.
19. UNAIDS, World Health Organization. AIDS Epidemic Update December 2001. Geneva: UN AIDS, WHO; 2001 (UN AIDS/01.74E; WHO document WHO/CDS/ CSR/NCS/2001.2).
20. Buve A, Bishikwabo-Nsarhaza K, Mutangadura G. AIDS in Africa. I: The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 2002;359:2011-7.
21. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167-74.
22. Lallemant M, Lallemant-Le-Coeur S, Cheynier D, Nzingoula S, Jourdain G, Sinet M, et al. Mother-child transmission of HIV-1 and infant survival in Brazzaville, Congo. AIDS 1989;3:643-6.
23. De Cock KM, Fowler M, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000;283:1175-82.
24. Ekpini ER, Wiktor SZ, Satten GA, Adjorlolo-Johnson GT, Sibailly TS, Ou CY, et al: Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet 1997;349:1054-9.
25. Dabis F, Msellati P, Dunn D, Lepage P, Newell ML, Peckham C, et al. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues, Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV. AIDS 1993;7:1139-48.
26. Dunn D, Newell M, Ades A, Peckham C. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-8.
27. Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA 2001;286:2413-20.
28. Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, et al. Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS 2000;14:453-9.
29. Marum LH, Tindyebwa D, Gibb D. Care of children with HIV infection and AIDS in Africa. AIDS 1997;11 Suppl B:S125-34.
30. Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola B, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. New England Journal of Medicine 1989;320:1637-42.
31. Marum LH, Bagenda D, Guay L, Aceng E, Kalyesubula I, Tindyebwe D, et al. Three-year mortality in a cohort of HIV-1 infected and uninfected Ugandan children. In: XI International AIDS Conference. Geneva: International AIDS Society; 1996. p. 25 (Abstract No. We.B.312).
32. Guay L, Hom D, Aceng E, Svilar G, Ndugwa C, Olness K, et al. Mortality and natural history experience in children of HIV-1 infected mothers in Uganda. In: IX International AIDS Conference. Geneva: International AIDS Society; 1993 (Abstract No. PO-C04-2675).
33. Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G, et al. Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). Journal of Acquired Immune Deficiency Syndromes 2002;31:327-30.
34. Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, et al. Morbidity among human immunodeficiency virus-1-infected and uninfected African children. Pediatrics [Online journal] 2000;106:e77. Available from: http://pediatrics.aappublications.org/cgi/content/full/106/6/e77
35. Dabis F, Ekpini E. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002;359:2097-104.
36. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. Journal of Pediatrics 1994;125:72-4.
37. Brena AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. Journal of Acquired Immune Deficiency Syndromes 1993;6:1125-9.
38. Oxtoby M, Ryder R, Mvula M, Nsa W, Baende E, Onorato I. Patterns of immunity to measles among African children infected with Human Immunodeficiency Virus. In: Epidemic Intelligence Service Conference. Atlanta (GA): Centers for Disease Control and Prevention; 1989. p. 31-2.
39. al-Attar I, Reisman J, Muehlmann M, McIntosh K. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal 1995;14:149-51.
40. Arpadi SM, Markowitz LE, Baughman AL, Shah K, Adam H, Wiznia A, et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 1996;97:653-7.
41. Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 1989;261:2512-6.
42. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal 1992;11:1008-14.
43. Thaithumyanon P, Punnahitananda S, Thisyakorn U, Praisuwanna P, Ruxrungtham K. Immune responses to measles immunization and the impacts on HIV-infected children. Southeast Asian Journal of Tropical Medicine and Public Health 2000;31:658-62.
44. Brunell PA, Vimal V, Sandu M, Courville TM, Daar E, Israele V. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;10:540-8.
45. Frenkel L, Nielsen K, Garakian A, Cherry J. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Archives of Pediatrics and Adolescent Medicine 1994;148:540-8.
46. Walter EB, Katz SL, Bellini WJ. Measles immunity in HIV-infected children. Pediatric AIDS and HIV Infection 1994;5:300-4.
47. Jason J, Murphy J, Sleeper LA, Donfield SM, Warrier I, Arkin S, et al. Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study Group. American Journal of Hematology 1994;46:29-35.
48. Permar SR, Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. Journal of Infectious Diseases 2001;183:532-8.
49. Melvin AJ, Mohan KM. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics 2003;111(6 Pt 1):e641-4 (also available from: http://pediatrics.aappublications.org/cgi/content/full/111/6/e641).
50. Berkelhamer S, Borock E, Elsen C, Englund J, Johnson D. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clinical Infectious Diseases 2001;32:1090-4.